title: Necrotizing Thrombophlebitis Secondary to Mycobacterium Chelonae in a Hemodialyzed Patient.
authors.affiliation: *Department of Dermatology, Hospital Universitario 12 de Octubre, Madrid, Spain †i+12 Research Institute, Universidad Complutense, Madrid, Spain Departments of ‡Nephrology, and §Pathology, Hospital Universitario 12 de Octubre, Madrid, Spain.
authors.forename: Lidia
authors.initials: L
authors.lastname: Maroñas-Jiménez
authors.forename: Sara
authors.initials: S
authors.lastname: Burillo-Martínez
authors.forename: Enrique
authors.initials: E
authors.lastname: Morales
authors.forename: Maria Concepción
authors.initials: MC
authors.lastname: Garrido-Ruiz
authors.forename: Jose Luis
authors.initials: JL
authors.lastname: Rodríguez-Peralto
mesh_terms: D000368:Aged; D000583:Amikacin / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001707:Biopsy, Needle; D017291:Clarithromycin / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006801:Humans; D007150:Immunohistochemistry; D007676:Kidney Failure, Chronic / Q000175:diagnosis / Q000628:therapy; D008297:Male; D009165:Mycobacterium Infections, Nontuberculous / Q000175:diagnosis* / Q000188:drug therapy; D016926:Mycobacterium chelonae / Q000187:drug effects / Q000302:isolation & purification*; D009336:Necrosis / Q000473:pathology; D011379:Prognosis; D006435:Renal Dialysis / Q000009:adverse effects* / Q000379:methods; D012720:Severity of Illness Index; D013924:Thrombophlebitis / Q000188:drug therapy / Q000209:etiology / Q000382:microbiology* / Q000473:pathology; D016896:Treatment Outcome
chemical_list: D000900:Anti-Bacterial Agents; D000583:Amikacin; D017291:Clarithromycin